VAERS 2404199
SANOFI PASTEUR · DTAP + IPV (QUADRACEL) · Charge UJ570AA
- Staat
- KS
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 08.08.2022
- Impfdatum
- 27.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Symptomtext
6 year old patient being behind on vaccination schedule and being administered QUADRACEL as her 4th DTAP dose instead of her 5th DTAP dose with no reported adverse event; Initial information received on 27-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 years old female patient who was being behind on vaccination schedule and being administered DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] as her 4th dtap dose instead of her 5th dtap dose with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE (HEPA [HEPATITIS A VACCINE]) for Prophylactic vaccination; and MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Prophylactic vaccination. On 27-Jul-2022, the patient received a 0.5ml dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE(formulation, strength was unknown, lot UJ570AA and expiry date was unknown) via intramuscular (Vastus lateralis ) route (unsure of which side) in the thigh nos for Immunization. Information regarding batch and expiry date was unknown. On 27-Jul-2022 the patient developed a non-serious 6 year old patient being behind on vaccination schedule and being administered quadracel as her 4th dtap dose instead of her 5th dtap dose with no reported adverse event (inappropriate schedule of product administration, latency: unknown) following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE. Action taken : not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -